Showing results (171-180 of 289) with videos related to
Sort By:
Pageof 29
Journal of Enzyme Inhibition|January 1, 1995
Characteristics of rabbit muscle adenylate kinase inhibition by sulfur and recovery by dithiothreitolP J Russell, A Williams, D Avila, et al.Cancer Chemotherapy and Pharmacology|January 1, 1989
A phase I study of trimetrexate (NSC 352122) administered by 5-day continuous intravenous infusionJ F Bishop, D Raghavan, I N Olver, et al.Acta Crystallographica. Section E, Structure Reports Online|January 24, 2014
3-[1-(4-Bromo-phen-yl)eth-oxy]-2,2,5-trimethyl-4-phenyl-3-aza-hexa-nePraveen Pitliya, Ray J Butcher, A Karim, et al.British Journal of Urology|May 1, 1992
Spinal cord compression in prostate cancer. A 10-year experienceM A Rosenthal, D Rosen, D Raghavan, et al.Seminars in Oncology|August 1, 1997
Paclitaxel and carboplatin in early phase studies: Roswell Park Cancer Institute experience in the subset of patients with lung cancerP J Creaven, D Raghavan, L Pendyala, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1984
Combination therapy with methotrexate and 5-fluorouracil: a prospective randomized clinical trial of order of administrationA S Coates, M H Tattersall, C Swanson, et al.The Prostate|January 1, 1986
Danazol treatment of advanced prostate cancer: clinical and hormonal effectsR M Cole, D Raghavan, I Caterson, et al.European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
The clinical development of paclitaxel and the paclitaxel/carboplatin combinationG N Schwartz, L Pendyala, H Kindler, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
A randomised cross-over trial of antiemetic therapy for platinum-based chemotherapy. Improved control with an intensive multiagent regimenM Findlay, R J Simes, K Cox, et al.Anticancer Research|March 1, 1997
Overexpression of c-erbB-2 mRNA and/or c-neu oncoprotein is a predictor for metastases from colorectal cancerJ L Yang, Y Yu, B Markovic, et al.Pageof 29